Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Healthcare providers need better education and policies to serve transgender individuals effectively.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Hirsutism causes significant psychological distress in women.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that a high-protein, low-carb diet can lead to significant weight loss but requires caution and further research.

Iodides can cause skin issues like acne and other health problems.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.